The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
about
The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The risk of febrile neutropeni ...... reactive protein by modelling.
@en
The risk of febrile neutropeni ...... reactive protein by modelling.
@nl
type
label
The risk of febrile neutropeni ...... reactive protein by modelling.
@en
The risk of febrile neutropeni ...... reactive protein by modelling.
@nl
prefLabel
The risk of febrile neutropeni ...... reactive protein by modelling.
@en
The risk of febrile neutropeni ...... reactive protein by modelling.
@nl
P2860
P50
P356
P1476
The risk of febrile neutropeni ...... reactive protein by modelling.
@en
P2093
Henrik Lindman
P2860
P304
P356
10.1111/BCP.13477
P407
P577
2017-11-26T00:00:00Z